YD Bio Ltd (YDES)

Price$3.54Cached quote
YDESNasdaq
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

3 annual periodsNewest to oldest
202520242023
Revenue$596,817$510,360$350,131
Gross profit$167,410$155,356$153,445
Gross margin28.05%30.44%43.83%
Research & development$1.6M$491,353$0
Operating expenses$5.4M$1.6M$163,292
Operating income−$5.3M−$1.5M−$9,847
Operating margin−883.31%−286.45%−2.81%
EBITDA−$5.3M−$1.5M−$7,395
EBITDA margin−880.58%−284.45%−2.11%
Net income−$8.3M−$1.4M$13,560
Net profit margin−1,392.61%−276.58%3.87%
Basic EPSper basic share-$0.12-$0.02$0.00
Diluted EPSper diluted share-$0.12-$0.02$0.00

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 16 reported holders of YDES
HolderShares held
Shen Ethan PhD
54.35M
Garrett Wealth Advisory Group, LLC
84.63K
GEODE CAPITAL MANAGEMENT, LLC
62.71K
Cypress Capital Management LLC (WY)
33.69K
Cerity Partners LLC
32.41K
Zhang Bo-Xiang
31.14K
CITADEL ADVISORS LLC
30.11K
JANE STREET GROUP, LLC
21.42K
UBS Group AG
12.38K
WOLVERINE ASSET MANAGEMENT LLC
4.89K
Lu Shao-Ta
2.08K
Chang Kochi
2.08K
MORGAN STANLEY
160
ROYAL BANK OF CANADA
117
WELLS FARGO & COMPANY/MN
75
FMR LLC
1

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about YDES yet. Start the conversation.

Write the first post